Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma

被引:25
|
作者
Lin, Ching-Jung [1 ]
Hsu, Teh-Fu [1 ,2 ,3 ]
Chang, Yen-Hou [1 ,3 ]
Huang, Ben-Shian [1 ,3 ,4 ]
Jiang, Ling-Yu [1 ,3 ]
Wang, Peng-Hui [1 ,3 ,4 ]
Chen, Yi-Jen [1 ,3 ,4 ,5 ]
机构
[1] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[5] Cheng Hsin Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
来源
关键词
Adenomyosis; Adenomyoma; Conservative uterine-sparing surgery; Gonadotropin releasing hormone agonist; Levonorgestrel-releasing intrauterine system; MEDICAL-TREATMENT; AND/OR ADENOMYOMA; PELVIC PAIN; THERAPY; TRIAL; WOMEN;
D O I
10.1016/j.tjog.2017.12.036
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate whether a maintenance levonorgestrel-releasing intrauterine system is effective for preventing the recurrence of postoperative adenomyosis-related symptoms. Materials and methods: From January 2005 through December 2014, a retrospective study including 133 patients with symptomatic adenomyosis undergoing conservative uterine-sparing surgery followed by gonadotropin-releasing hormone agonist treatment was conducted. We excluded the 18 patients who did not meet the inclusion criteria. The patients of intervention group (n = 54) received a levonorgestrelreleasing intrauterine system (LNG-IUS), which was inserted after surgery. The patients without LNG-IUS insertion were enrolled in the control group (n = 61). The primary outcome was improvement of adenomyosis-related dysmenorrhea, which was evaluated by the visual analog scale (VAS) and by hemoglobin (Hgb) and CA-125 levels. Results: Over a 12-month follow-up, the intervention group exhibited a greater reduction in dysmenorrhea as assessed with a VAS score (mean +/- SD: 6.5 +/- 2.5 vs 4.1 +/- 3.6, p = 0.001) and a greater elevation in the Hgb level (2.1 +/- 1.9 vs 1.0 +/- 1.7, p = 0.008) than the control group. At the end of the 24-month follow-up period, the intervention group also exhibited a greater reduction in dysmenorrhea as assessed with a VAS score (mean +/- SD 6.1 +/- 2.7 vs 3.7 +/- 3.7, p = 0.002) and a greater elevation in the Hgb level (1.9 +/- 2.1 vs 0.7 +/- 1.8, p = 0.022) than the control group. The CA-125 level was significantly lower in the intervention group during the postoperative follow up (12th month follow-up, intervention vs control, 24.5 +/- 28.8 vs 50.1 +/- 44.0, p = 0.005; 24th month follow-up, 28.6 +/- 26.2 vs 75.4 +/- 68.5, p = 0.002). Conclusion: The maintenance therapy of LNG-IUS is effective and well accepted for long-term therapy after conservative surgery for patients with adenomyosis. (C) 2018 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 50 条
  • [1] Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system
    Li, Lei
    Leng, Jinhua
    Jia, Shuangzheng
    Lang, Jinghe
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (03) : 357 - 363
  • [2] Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma
    Kriplani, Alka
    Awasthi, Divya
    Kulshrestha, Vidushi
    Agarwal, Nutan
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 116 (01) : 35 - 38
  • [3] Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
    Silva, JCRE
    Silva, ACJSRE
    Reis, FJC
    Manetta, LA
    Ferriani, RA
    Nogueira, AA
    [J]. RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 388 - 391
  • [4] Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
    Silva, JCRE
    Silva, ACJDRE
    dos Reis, FJC
    Manetta, LA
    Ferriani, RA
    Nogueira, AA
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (08) : 613 - 617
  • [5] Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study
    Qiu, Haifeng
    Yuan, Zhongfu
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (06) : 708 - 708
  • [6] Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study
    Chen, Yi-Jen
    Hsu, Teh-Fu
    Huang, Ben-Shian
    Tsai, Hsiao-Wen
    Chang, Yen-Hou
    Wang, Peng-Hui
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (06) : 582.e1 - 582.e9
  • [7] Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review
    Jiang, Wenxiao
    Shen, Qi
    Chen, Miaomiao
    Wang, Ying
    Zhou, Qingfeng
    Zhu, Xuejie
    Zhu, Xuegiong
    [J]. STEROIDS, 2014, 86 : 69 - 78
  • [8] Uterine perforation in women using a levonorgestrel-releasing intrauterine system
    Van Houdenhoven, K
    van Kaam, K
    van Grootheest, AC
    Salemans, THB
    Dunselman, GAJ
    [J]. CONTRACEPTION, 2006, 73 (03) : 257 - 260
  • [9] Successful laparotomy tumor resection and levonorgestrel-releasing intrauterine system for atypical polypoid adenomyoma
    Narumi, Risa
    Takei, Yuji
    Morisawa, Hiroyuki
    Taneichi, Akiyo
    Matsubara, Shigeki
    Fujiwara, Hiroyuki
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (01) : 230 - 234
  • [10] The levonorgestrel-releasing intrauterine system for menorrhagia
    Lewis, P
    Selvakumari, NK
    Neelapalla, S
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (01): : 46 - 46